Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals — Stella

Recruiting

Back to HIV trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Tianjin Second People's Hospital, Tianjin, Tianjin Municipality

Key details

Phase

Early testing / Safety & dosing

Sponsor

Shanxi Kangbao Biological Product Co., Ltd.

Collaborators

Chinese Academy of Medical Sciences

Enrollment target

~30 participants

Started

January 2026

Primary completion

July 2026

Age range

18 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov